Rahsaan W. Thompson serves as Chief Legal Officer, Secretary, and Compliance Officer at Zevra Therapeutics Inc., a clinical-stage rare disease therapeutics company focused on developing novel treatments for neurological and neuropsychiatric disorders. In this multifaceted role, he oversees all legal matters, including corporate governance, regulatory compliance, intellectual property strategy, and risk management, while also acting as corporate secretary to ensure seamless board and shareholder interactions. Thompson's leadership has been instrumental in guiding Zevra through key milestones, such as FDA submissions, strategic partnerships, and capital raises, fortifying the company's position in the competitive biotech landscape. With over 20 years of experience in the pharmaceutical and biotechnology sectors, Thompson began his career at a premier international law firm, where he specialized in life sciences transactions, mergers and acquisitions, and securities law. He later held senior in-house positions at notable biotech firms, including General Counsel roles at publicly traded companies, where he spearheaded complex licensing agreements and navigated intricate regulatory environments. His expertise earned him recognition as a leading legal advisor in healthcare, with notable achievements including the successful execution of a $100 million+ financing round and the defense of high-stakes patent litigations. Thompson holds a J.D. from Harvard Law School and a B.A. from Morehouse College. A sought-after speaker on compliance and governance in biotech, he is committed to fostering ethical practices and innovation at Zevra, positioning the company for sustained growth and impactful patient outcomes.